American Society of Anesthesiologists Announces New Industry Supporter Pacira BioSciences, Inc.
October 12 2023 - 8:00AM
The American Society of Anesthesiologists (ASA) today announced
Pacira BioSciences, Inc. (Nasdaq: PCRX) has joined ASA’s Industry
Supporter Program to support the Society’s more than 56,000
physician anesthesiologist members to improve patient care and
reduce reliance on opioids for the treatment of postsurgical or
chronic pain.
“We are delighted to establish this collaboration with Pacira,
which we believe represents an excellent opportunity to advance
education and innovation for our members,” said ASA President
Michael Champeau, M.D., FAAP, FASA. “Pacira and the ASA share a
mutual commitment toward best-in-class pain medicine and optimizing
patient outcomes, and we look forward to working together to
advance these shared goals.”
As an Industry Supporter, Pacira is helping to establish a
strong, mutually beneficial relationship with the anesthesiology
community, strengthen collaboration between physician
anesthesiologists and industry, and add to the value the Society
provides to patients and the public, while providing invaluable
year-round support of ASA programs and priorities related to
non-opioid alternatives and postsurgical care.
Through the program, Pacira is supporting ASA’s major events,
including this year’s ANESTHESIOLOGY® annual meeting, with valuable
educational resources to improve patient care.
“Pacira is pleased to support ASA and we look forward to
collaborating in our efforts to improve patient outcomes through
opioid-minimizing strategies,” said Dave Stack, CEO and Chairman of
Pacira. “Our organizations share a common interest in advancing
education and innovation for the anesthesia community and the
patients we serve. We believe that working together, Pacira and the
ASA can effect significant change in the best interest of
patients.”
Launched in 2010, ASA’s Industry Supporter Program is limited to
10 organizations at any time. Participation is intended for
companies who want to stand apart by showcasing high-level
commitment to the education of physician anesthesiologists, the
anesthesia care team and advancement of the specialty.
About the American Society of
Anesthesiologists
Founded in 1905, the American Society of Anesthesiologists (ASA)
is an educational, research, and scientific professional society
with more than 56,000 members organized to advance the medical
practice of anesthesiology and secure its future. ASA is committed
to ensuring anesthesiologists evaluate and supervise the medical
care of all patients before, during, and after surgery. ASA members
also lead the care of critically ill patients in intensive care
units, as well as treat pain in both acute and chronic
settings.
For more information on the field of anesthesiology, visit the
American Society of Anesthesiologists online at asahq.org. To learn
more about how physician anesthesiologists help ensure patient
safety, visit www.asahq.org/MadeforThisMoment. Like ASA on
Facebook, follow ASALifeline on Twitter.
About Pacira
Pacira BioSciences, Inc. (Nasdaq: PCRX) has three
commercial-stage products: EXPAREL® (bupivacaine liposome
injectable suspension), ZILRETTA® (triamcinolone acetonide
extended-release injectable suspension), and ioveraº®, a novel,
handheld device for delivering immediate, long-acting, drug-free
pain control using precise, controlled doses of cold temperature to
a targeted nerve. Pacira is also developing other innovative
products to address debilitating conditions such as cardiac
electrical storm, atrial fibrillation, chronic pain, and
spasticity. To learn more about Pacira, visit www.pacira.com.
Investor Contact:
Pacira:
Susan Mesco, (973) 451-4030
susan.mesco@pacira.com
Media Contact:
ASA:
Theresa Hill (773) 330-5273
t.hill@asahq.org
Pacira:
Amber Sears, (973) 254-3587
amber.sears@pacira.com
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Jun 2024 to Jul 2024
Pacira BioSciences (NASDAQ:PCRX)
Historical Stock Chart
From Jul 2023 to Jul 2024